Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 293(2): 599-606, 2000 May.
Article in English | MEDLINE | ID: mdl-10773034

ABSTRACT

To characterize age-related changes in beta-adrenergic responsiveness and to test the hypothesis that an increase in the effects of adenosine contribute to impaired beta-adrenergic responsiveness, Fischer 344 rat right atria (RA), left atria (LA), and left ventricular trabeculae carnae were exposed to the beta-receptor agonist isoproterenol (ISO), followed by four doses of the selective adenosine A(1) receptor agonist cyclopentyladenosine (CPA). Spontaneous contractile rates of adult RA were inhibited more than senescent RA by CPA. Contractility (+dF/dt) of adult LA was reduced more than senescent LA by CPA. Left trabeculae carnae tissue responded weakly to CPA, but senescent tissue was less responsive than adult tissue. Senescent atrial A(1) receptor density was 56% greater than in adult tissue, whereas the density in senescent ventricles was 39% lower than in adult tissue. No significant difference in antagonist affinities (K(d)) of A(1) receptor was observed between adult and senescent atria. In addition, agonist competition curves indicated a significant increase in senescent atrial and a decrease in senescent ventricular tissue in the affinity of agonist for high-affinity A(1) receptors with no difference in dissociation constant (K(i)). No significant age-related differences in atrial or ventricular tissues occurred in either the antagonist affinity (K(d)) or density (B(max)) of the beta-adrenergic receptors. CPA was found to inhibit ISO-stimulated adenylate cyclase activity more in senescent than in adult atrial and ventricular membrane preparations. We conclude that age-related differences in functional response to ISO and CPA, A(1) receptor density, and ISO-stimulated adenylate cyclase activity differ in atrial and ventricular myocardium.


Subject(s)
Adenosine/analogs & derivatives , Adrenergic beta-Agonists/pharmacology , Aging/physiology , Cardiotonic Agents/pharmacology , Heart/drug effects , Isoproterenol/pharmacology , Purinergic P1 Receptor Agonists , Adenosine/pharmacology , Adenylyl Cyclase Inhibitors , Adenylyl Cyclases/metabolism , Animals , Electric Stimulation , Heart/growth & development , Heart Atria/drug effects , Heart Ventricles/drug effects , In Vitro Techniques , Myocardial Contraction/drug effects , Myocardium/enzymology , Radioligand Assay , Rats , Rats, Inbred F344 , Receptors, Adrenergic, beta/drug effects , Xanthines/pharmacokinetics
2.
J Neurosci Methods ; 68(1): 101-11, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8884619

ABSTRACT

We developed a method for determining whether channels in a multichannel patch or bilayer have the same or statistically significantly different open probabilities. We use a maximum likelihood method to fit the distribution of (unbinned) current amplitudes and to provide estimates of individual channel open probabilities, single channel currents, and standard deviations of the channel currents. These parameters are used to compare models with increasing constraints on the open probabilities including the model where all channels have different open probabilities and the model where all channels have the same open probability. A chi 2 statistic is used to identify models that are statistically less likely to predict the data. The ability of multichannel data to determine individual open probabilities is limited by two factors: the signal to noise ratio of the record and the fact that changes in amplitude distributions caused by a 0.2 difference in open probabilities are comparable in magnitude to the variations caused by random channel gating. These limitations notwithstanding, we demonstrate the utility of our approach by using it to analyze the open probabilities of 3 large conductance Ca2(+)-activated K+ channels in an artificial lipid bilayer revealing the response of one of those channels to GTP gamma S.


Subject(s)
Ion Channels/physiology , Models, Theoretical , Patch-Clamp Techniques/methods
3.
Am J Physiol ; 266(3 Pt 1): C601-10, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8166223

ABSTRACT

We compared the gating, ion conduction, and pharmacology of large-conductance Ca(2+)-activated K+ channels (BK channels) from canine colon in artificial lipid bilayers and in excised patches. Both protocols identified 270-pS K(+)-selective channels activated by depolarization and Ca2+ (approximately 130-mV shift of half-activation voltage per 10-fold change in Ca2+) that were inhibited by extracellular tetraethylammonium (TEA) and charybdotoxin. These similarities suggest that the same BK channels are studied in the two techniques. However, we found three quantitative differences between channels in artificial bilayers and patches. 1) Channels in artificial bilayers required fivefold higher free Ca2+ or 80-mV stronger depolarization for activation. 2) The voltage dependence of TEA block was smaller for channels in artificial bilayers. The apparent distance across the membrane field for the TEA binding site was 0.031 for channels in artificial bilayers and 0.23 for channels in patches. 3) ATP (2 mM) decreased open probability (Po) of channels in artificial bilayers, whereas channels in patches were unaffected. Neither GTP nor UTP reduced Po of channels in artificial bilayers. It is possible that these differences may be due to a lack of molecular identity between the channels studied in the two protocols. Alternatively, they may be attributed to alterations in channel properties during reconstitution or to influences of the artificial lipid environment.


Subject(s)
Calcium/physiology , Potassium Channels/physiology , Adenosine Triphosphate/pharmacology , Animals , Colon/metabolism , Dogs , Electric Conductivity , Electrophysiology , Ion Channel Gating , Lipid Bilayers/metabolism , Muscle, Smooth/metabolism , Potassium Channel Blockers , Potassium Channels/drug effects , Tetraethylammonium , Tetraethylammonium Compounds/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL